Can Resistance Enhance Selection of Treatment? (CREST)
This study has been completed.
Sponsor:
Kirby Institute
Collaborators:
Abbott
Boehringer Ingelheim Pharmaceuticals
GlaxoSmithKline
Bristol-Myers Squibb
Merck
Roche Pharma AG
Virco
Diagnostic Technology
Perkin Elmer Inc.
Information provided by:
Kirby Institute
ClinicalTrials.gov Identifier:
NCT00262717
First received: December 6, 2005
Last updated: June 8, 2006
Last verified: June 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | August 2002 |
| Estimated Primary Completion Date: | No date given |